Sex differences in efficacy and toxicity of systemic treatments are an undervalued issue in the era of precision oncology

Sex differences in efficacy and toxicity of systemic treatments are an undervalued issue in the era of precision oncology

Où? Lausanne, Switzerland

Quand? 30.11.2018 au 01.12.2018

Gender medicine aims to improve the treatment of women as well as men. During the workshop, this concept, initially developed by cardiologists such as Marianne Legato and Vera Regitz-Zagrosek, will be presented together with examples of sex differences in disease biology and treatment outcomes from various fields of oncology. The theoretical aspects, for example of disease biology and pharmacology, will be reviewed and their implications for the field of oncology will be discussed with a multidisciplinary faculty and audience.